KFGK
EBS icon

Keystone Financial Group (Kentucky)’s Emergent Biosolutions EBS Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
28,488
-300
-1% -$2.51K 0.01% 492
2026
Q1 		$239K Sell
28,788
-300
-1% -$3.11K 0.02% 449
2025
Q4 		$360K Sell
29,088
-2,187
-7% -$23.4K 0.03% 313
2025
Q3 		$276K Buy
31,275
+950
+3% +$7.39K 0.02% 341
2025
Q2 		$193K Buy
30,325
+11,600
+62% +$66.4K 0.02% 405
2025
Q1 		$91K Buy
+18,725
New +$155K 0.01% 386

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s EBS Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) reduced its Emergent Biosolutions (EBS) stake by 1% in Q2 2026, selling an estimated $2.51K and leaving 28,488 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #492.

Keystone Financial Group (Kentucky) first reported a position in EBS in Q1 2025 and has held it in 6 quarters since. The position peaked at $360K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 28,488 shares of Emergent Biosolutions worth $239K as of Q2 2026.
  • Keystone Financial Group (Kentucky) sold 300 Emergent Biosolutions shares in Q2 2026, an estimated $2.51K.
  • Emergent Biosolutions made up 0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #492 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Emergent Biosolutions in Q1 2025 and has held it in 6 quarters since.
  • Keystone Financial Group (Kentucky)'s Emergent Biosolutions position peaked at $360K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.